| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/1997 | WO1997019701A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 06/05/1997 | WO1997019700A1 Novel drug for relieving pain and promoting the removal of calculi in urolithiasis |
| 06/05/1997 | WO1997019697A1 Method of using beta-interferons to treat restenosis |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019694A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | WO1997019691A1 Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
| 06/05/1997 | WO1997019686A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | WO1997019685A1 The use of cholinesterase inhibitors in the treatment of xerostomia |
| 06/05/1997 | WO1997019684A1 Retinoic acid treatment of cardiac arrhythmia |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | WO1997019681A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
| 06/05/1997 | WO1997019680A1 Therapeutical use of beta-mimetic agents for the transmucosal treatment of dysmenorrhoea |
| 06/05/1997 | WO1997019679A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 06/05/1997 | WO1997019678A1 Improved perfluorocarbons for biological gas exchange and method |
| 06/05/1997 | WO1997019677A1 Sustained-release drug delivery system |
| 06/05/1997 | WO1997019675A2 Complex cationic lipids |
| 06/05/1997 | WO1997019673A2 Reduction of hair growth |
| 06/05/1997 | WO1997019672A1 Reduction of hair growth |
| 06/05/1997 | WO1997019669A2 Heterocyclic compounds and their use |
| 06/05/1997 | WO1997019593A1 Antimicrobial composition and methods of use therefor |
| 06/05/1997 | WO1997014712A3 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
| 06/05/1997 | WO1997013776A3 Novel amine derivatives of epipodophyllotoxin 2', 3'-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 06/05/1997 | WO1997013772A3 Cephalosporin antibiotics |
| 06/05/1997 | WO1997012583A3 Stable compositions containing n-propargyl-1-aminoindan |
| 06/05/1997 | WO1997012036A3 Bone stimulating factor |
| 06/05/1997 | WO1997010810A3 Pharmaceutical granules |
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | WO1997009973A3 Peripherally active anti-hyperalgesic opiates |
| 06/05/1997 | WO1997006770A3 Chitin extract for treatment of skin disease |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | DE19545180A1 Treatment of pain resulting from rheumatism, arthritis or arthrosis, |
| 06/05/1997 | DE19545044A1 Endoparasitizide Mittel Endoparasiticides means |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | DE19544685A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | DE19544635A1 Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New amino alcohol derivatives, processes for their preparation and medicaments containing these compounds |
| 06/05/1997 | DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/05/1997 | DE19544449A1 Pulverförmige Iod-Komplexe Powdered iodine complexes |
| 06/05/1997 | DE19544414A1 New tropolone substituted bismuth compounds |
| 06/05/1997 | DE19544212A1 Neue LH-RH-Antagonisten mit verbesserter Wirkung New LH-RH antagonists with improved activity |
| 06/05/1997 | CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | CA2238930A1 Sustained-release drug delivery system |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238812A1 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives |
| 06/05/1997 | CA2238770A1 Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis |
| 06/05/1997 | CA2238762A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration |
| 06/05/1997 | CA2238647A1 Hollow-tube brachytherapy device |
| 06/05/1997 | CA2238570A1 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | CA2238555A1 Heterocyclic compounds and their use |
| 06/05/1997 | CA2238484A1 Antimicrobial composition and methods of use therefor |
| 06/05/1997 | CA2238328A1 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (nk-3)- and neurokinin 2 (nk-2) receptor antagonists. |
| 06/05/1997 | CA2238312A1 Salts of quinoline derivatives as nk3 antagonists |
| 06/05/1997 | CA2237956A1 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones |
| 06/05/1997 | CA2237850A1 Treatment of inflammation by inhibition of lipid body formation |
| 06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | CA2236794A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | CA2235937A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them |
| 06/05/1997 | CA2235936A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | CA2222790A1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776898A1 Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide |
| 06/04/1997 | EP0776896A1 Heterocyclic compounds and their use |
| 06/04/1997 | EP0776895A1 Protein kinase C inhibitor |
| 06/04/1997 | EP0776893A1 Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776667A2 Anti-ulcerative drug |
| 06/04/1997 | EP0776666A2 Analgesic anti-inflammatory drug |
| 06/04/1997 | EP0776665A1 Compositons for the prevention and treatment of urogenital disorders, containing bismuth |
| 06/04/1997 | EP0776664A2 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 06/04/1997 | EP0776663A1 Remedy for myotonic dystrophy |
| 06/04/1997 | EP0776662A1 Pharmaceutical compositions containing mequitazine |
| 06/04/1997 | EP0776661A1 Combined preparation of antiestrogen and glucocorticoid for the treatment of autoimmune disease |
| 06/04/1997 | EP0776660A2 Long-lasting release nifedipine preparation |
| 06/04/1997 | EP0776359A1 Regulated apoptosis |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776332A1 NEW PEPTIDE DERIVATIVES WITH $g(d) OPIOID RECEPTOR ANTAGONIST OR MIXED $g(m) AGONIST/$g(d) ANTAGONIST EFFECTS |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776328A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 06/04/1997 | EP0776327A1 New multimerizing agents |
| 06/04/1997 | EP0776326A1 Pyrrolinone-based peptidomimetics |
| 06/04/1997 | EP0776325A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 06/04/1997 | EP0776324A1 Endothelin antagonists |
| 06/04/1997 | EP0776323A1 Salts of an anti-migraine indole derivative |
| 06/04/1997 | EP0776211A1 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776208A1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 06/04/1997 | EP0776207A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
| 06/04/1997 | EP0776206A1 Pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 06/04/1997 | EP0776205A1 Pharmaceutical formulation |
| 06/04/1997 | EP0776204A1 Indole alkaloids useful as uv protective and anti-inflammatory agents |
| 06/04/1997 | EP0776203A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 06/04/1997 | EP0776202A1 Liposome-encapsulated taxol, its preparation and its use |
| 06/04/1997 | EP0776201A1 Composition and method for treating anxiety |
| 06/04/1997 | EP0776200A1 Composition and method for protection against drug dependency |
| 06/04/1997 | EP0776199A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 06/04/1997 | EP0776198A1 Transdermal therapeutic system with protection against hydrolysis |
| 06/04/1997 | EP0776197A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |